Of the pro-inflammatory cytokines, IL-17A has recently been associated with the progression of various types of tumor [25–32] and is considered to be an important target for cancer therapy because its inhibition reduces cancer progression in animal models [33, 34]. The gene discussed is IL17A; the disease is neoplasm.